Search

everythinglearnresearchcommunity

for

Search:↓

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

During COVID-19, Iraqi women experienced more hair loss and skin issues like acne, likely due to stress and mask-wearing.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

Hospitalized COVID-19 survivors have a higher risk of long-term symptoms and need special care.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Anemia increases the risk of hair loss in post-COVID-19 survivors.

Thrombophilic conditions may worsen Long COVID symptoms due to increased blood clotting.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

The pandemic changed the types of skin conditions seen, not the number of visits.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Severe hair loss may increase the risk of dying from COVID-19.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.